[go: up one dir, main page]

HK1001821A1 - A slimming pharmaceutical composition - Google Patents

A slimming pharmaceutical composition

Info

Publication number
HK1001821A1
HK1001821A1 HK98100528A HK98100528A HK1001821A1 HK 1001821 A1 HK1001821 A1 HK 1001821A1 HK 98100528 A HK98100528 A HK 98100528A HK 98100528 A HK98100528 A HK 98100528A HK 1001821 A1 HK1001821 A1 HK 1001821A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
ephedrine
human
reducing
slimming
Prior art date
Application number
HK98100528A
Other languages
English (en)
Inventor
Arne Astrup
Original Assignee
Nycomed Danmark A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark A S filed Critical Nycomed Danmark A S
Publication of HK1001821A1 publication Critical patent/HK1001821A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98100528A 1989-07-07 1998-01-21 A slimming pharmaceutical composition HK1001821A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK339289A DK339289D0 (da) 1989-07-07 1989-07-07 Farmaceutisk praeparat
PCT/DK1990/000106 WO1991000730A1 (en) 1989-07-07 1990-04-20 A slimming pharmaceutical composition

Publications (1)

Publication Number Publication Date
HK1001821A1 true HK1001821A1 (en) 1998-07-10

Family

ID=8122369

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98100528A HK1001821A1 (en) 1989-07-07 1998-01-21 A slimming pharmaceutical composition

Country Status (19)

Country Link
US (1) US5422352A (da)
EP (1) EP0480934B1 (da)
JP (1) JP2584899B2 (da)
KR (1) KR0159045B1 (da)
AT (1) ATE107858T1 (da)
AU (1) AU638992B2 (da)
CA (1) CA2063598C (da)
DE (1) DE69010336T2 (da)
DK (2) DK339289D0 (da)
ES (1) ES2055911T3 (da)
FI (1) FI920026A0 (da)
HK (1) HK1001821A1 (da)
HU (1) HU220071B (da)
LT (1) LT3536B (da)
LV (1) LV10192B (da)
NO (1) NO920051L (da)
RU (1) RU2109511C1 (da)
UA (1) UA27779C2 (da)
WO (1) WO1991000730A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5865869A (en) * 1991-08-02 1999-02-02 Ecologel Usa, Inc. Solution for plant root watering
WO1994000432A1 (en) * 1992-06-30 1994-01-06 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anorectic epinephrine derivatives
JPH08509203A (ja) * 1992-10-15 1996-10-01 ダナ−ファーバー キャンサー インステテュート インコーポレイテッド ＴＮＦ−α作用の拮抗剤を用いる肥満関連糖尿病▲ＩＩ▼型のインスリン耐性の治療
ES2094687B1 (es) * 1994-08-02 1997-12-16 S A L V A T Lab Sa Combinacion farmaceutica contra la obesidad o el sobrepeso.
FR2746644A1 (fr) * 1996-03-18 1997-10-03 Firion Jackie Produit parapharmaceutique moderateur d'appetit
CA2248854C (en) * 1996-09-30 2004-03-30 Dennis Jones The regulation of appetite, body weight and athletic function with materials derived from citrus varieties
US6224873B1 (en) 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
ES2259806T5 (es) 1996-12-23 2009-05-01 S.L.A. Pharma Ag Composicion farmaceutica para tratar la incontinencia fecal.
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US7232830B2 (en) 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
AU744550B2 (en) 1998-06-26 2002-02-28 Elaine A. Delack Treatment for multiple sclerosis
US6340482B1 (en) * 2000-05-18 2002-01-22 Zhishin, Llc Methods for inducing weight loss in a human with materials derived from Citrus varieties
US6113949A (en) * 1998-10-27 2000-09-05 Prolab Nutrition, Inc. Weight control product and method of treating hyperlipidemia and increasing vigor with said product
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US6576272B1 (en) * 1999-03-05 2003-06-10 Twin Laboratories Incorporated Dietary supplement and method of using same
WO2001005356A2 (en) * 1999-07-20 2001-01-25 Natrol, Inc. Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant
WO2001013935A2 (en) * 1999-08-23 2001-03-01 The Administrators Of The Tulane Educational Fund Modulation of the blood-brain barrier transporter for leptin
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
DE10011541A1 (de) * 2000-03-06 2001-09-20 Reimann Hartmut Verwendung einer Kombination aus Ephedrin und Coffein und/oder Theophyllin zur Vitalisierung von Knochenfischen, Wasserzusatz zur Vitalisierung von Knochenfischen
US6316499B1 (en) 2000-05-18 2001-11-13 Zhishin, Llc Methods for increasing the muscle mass of a human with materials derived from citrus varieties
KR20030005204A (ko) * 2000-12-25 2003-01-17 가부시키가이샤 시세이도 교감신경 활성화 향료 조성물
US7048941B2 (en) * 2001-03-30 2006-05-23 New World Enterprizes, Inc. Chocolate composition as delivery system for nutrients and medications
US7041305B2 (en) * 2001-09-07 2006-05-09 Western Holdings, Llc Stable water in oil aminophylline emulsions
GB0130763D0 (en) 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
WO2003088953A2 (en) * 2002-04-19 2003-10-30 N.V. Nutricia Multiphasic diet
US8142810B2 (en) * 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
US20040224031A1 (en) * 2003-05-06 2004-11-11 Antonio Zorzano Olarte Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus
US20050130933A1 (en) * 2003-10-17 2005-06-16 Ira Jacobs Weight-loss supplement
CA2545559A1 (en) * 2003-11-20 2005-06-09 Alteragon Pty Ltd. Method of decreasing fat deposits and body weight in mammals and birds
CA2455248A1 (en) * 2004-01-29 2005-07-29 Alexander Zolotoy Oral administration of r-albuterol against obesity
US7524064B2 (en) * 2004-03-09 2009-04-28 Research Foundation Of The State University Of New York Apparatus and method for assessing retinal damage
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20060134230A1 (en) * 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US20060204599A1 (en) * 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US9610429B2 (en) * 2010-12-29 2017-04-04 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with targeted substance delivery
AU2013330213B2 (en) * 2012-10-08 2016-04-14 Rivalea (Australia) Pty Ltd Animal feed supplement comprising ractopamine and caffeine
US9877434B2 (en) 2013-05-30 2018-01-30 Ecologel Solutions, Llc Granular compositions and methods for drought mitigation
US10143664B2 (en) * 2014-03-26 2018-12-04 Rivalea (Australia) Pty Ltd Method for improving feed efficiency in ruminants
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
MX2017010321A (es) 2015-02-13 2017-12-07 Mars Inc Sistema de alimentacion para mascotas.
WO2016167855A1 (en) * 2015-04-14 2016-10-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Combination of albuterol and caffeine as synergistic treatment for obesity or sarcopenia
GB201522296D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat
AU2020276619A1 (en) 2019-05-16 2021-12-16 Nexus Pharmaceuticals, Inc. Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390164A1 (fr) * 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
NL7710582A (nl) * 1977-06-03 1978-12-05 Pharmaceutical Export Promotio Werkwijze ter bereiding van een vermagerings- preparaat.
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5011843A (en) * 1988-05-31 1991-04-30 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors

Also Published As

Publication number Publication date
EP0480934A1 (en) 1992-04-22
LV10192A (lv) 1994-10-20
DE69010336D1 (de) 1994-08-04
RU2109511C1 (ru) 1998-04-27
HU9200051D0 (en) 1992-06-29
DK0480934T3 (da) 1994-11-07
WO1991000730A1 (en) 1991-01-24
AU638992B2 (en) 1993-07-15
NO920051D0 (no) 1992-01-03
LTIP702A (en) 1995-01-31
EP0480934B1 (en) 1994-06-29
HU220071B (hu) 2001-10-28
CA2063598C (en) 1997-12-09
CA2063598A1 (en) 1991-01-08
UA27779C2 (uk) 2000-10-16
DK339289D0 (da) 1989-07-07
DE69010336T2 (de) 1994-11-03
US5422352A (en) 1995-06-06
LT3536B (en) 1995-11-27
LV10192B (en) 1995-06-20
FI920026A0 (fi) 1992-01-03
JP2584899B2 (ja) 1997-02-26
AU5630890A (en) 1991-02-06
ATE107858T1 (de) 1994-07-15
ES2055911T3 (es) 1994-09-01
KR0159045B1 (ko) 1998-12-01
JPH04507091A (ja) 1992-12-10
NO920051L (no) 1992-01-31
HUT62798A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
LTIP702A (en) A slimming pharmaceutical composition
EP0552256A4 (da)
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
ATE239482T1 (de) Neue arzneiformulierung
HK1003980A1 (en) Dosage form for dispensing drug and human therapy
NO169291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
HK1048058A1 (zh) 肝臟選擇性的藥用活性物
PT977564E (pt) Forscolina para promocao da massa corporal magra
ES2010561A6 (es) Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina.
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
EP0214254A1 (en) MELATONIN COMPOSITIONS AND USES THEREOF.
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
CA2222698A1 (fr) Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
MX9706689A (es) Tratamiento de trastornos causados por el factor de crecimiento de citocina.
IL126175A (en) Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
GB2004183A (en) Compositions containing caffeine and ephedrine or their derivatives
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
KR900017599A (ko) 종양 치료용 약학 조성물
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
IT1200350B (it) Supporto a pedana per il corpo umano nella pratica dell'idromassaggio adattabile al fondo

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060420